Site logo
Site logo
Mobile logo
  • Home
  • About
  • NYC TMS Services
  • NYC Spravato Services
  • Insurance Coverage
  • FAQs
  • Blog
  • Contact

Depression

Depression Efficacy and Safety of Intranasal Esketamine (Spravato) for Depression: An Update
April 24, 2024in Depression 0 Comments 0 Likes

Efficacy and Safety of Intranasal Esketamine (Spravato) for Depression: An Update

Research on the efficacy and safety of intranasal esketamine (Spravato) as a treatment for Depression continues. In particular, three recent analyses provide additional background for patients interested in learning more

by Dr. Bryan Bruno, Medical Director
Depression Akathisia from Antidepressants
April 23, 2024in Depression 0 Comments 0 Likes

Akathisia from Antidepressants

Finding the right treatment plan to combat major depressive disorder (MDD) is a complicated and delicate endeavor.  While some antidepressants may work to help alleviate the daily burdens of Depression,

by Dr. Bryan Bruno, Medical Director
Depression Do SSRIS affect fertility? The effect of SSRIs on Semen quality
April 22, 2024in Depression 0 Comments 0 Likes

Do SSRIS affect fertility? The effect of SSRIs on Semen quality

When it comes to comprehensive treatment plans for mood disorders such as Depression and anxiety, selective serotonin reuptake inhibitors (SSRIs) have long been considered a frontline treatment strategy. While antidepressants

by Dr. Bryan Bruno, Medical Director
Depression Esketamine (Spravato) Treatment as Part of a Depression Relapse Prevention Plan
April 21, 2024in Depression 0 Comments 0 Likes

Esketamine (Spravato) Treatment as Part of a Depression Relapse Prevention Plan

Although millions of people are empowered to coexist with their Depression through comprehensive and personalized treatment plans, the long-term management of this condition can often be complicated by the potential

by Dr. Bryan Bruno, Medical Director
Depression Antidepressant Induced Mania
April 11, 2024in Depression 0 Comments 0 Likes

Antidepressant Induced Mania

For decades, antidepressants such as SSRIs have long been regarded as first-line treatment for major depressive disorder (MDD) and other mood disorders; their importance across many different demographics continues to

by Dr. Bryan Bruno, Medical Director
Depression Pharmacogenetic testing for depression represented by a medical provider explaining something to a patient.
April 2, 2024in Depression 0 Comments 0 Likes

Pharmacogenetic Testing for Depression: An Update

Selecting effective antidepressants for the treatment Major Depressive Disorder (MDD) is an imprecise practice, with remission rates of just about 30% at the initial treatment choice.  The potential of pharmacogenetic

by Dr. Bryan Bruno, Medical Director
Depression A Study of Single-Dose Psilocybin Treatment for Major Depressive Disorder
March 24, 2024in Depression 0 Comments 0 Likes

A Study of Single-Dose Psilocybin Treatment for Major Depressive Disorder

Psilocybin Treatment for Major Depressive Disorder (MDD) is a topic of interest for some of the many people struggling with debilitating symptoms of Depression. While not currently approved for the

by Dr. Bryan Bruno, Medical Director
Depression A pharmacist explaining the Auvelity experience that patients have with this new medication.
March 12, 2024in Depression 0 Comments 0 Likes

A New Antidepressant: Discussing Patients’ Auvelity Experience

Whenever a new antidepressant becomes available, patients will want to know what it is like to take it. For this reason, we bring you this discussion of the Auvelity experience

by Dr. Bryan Bruno, Medical Director
Depression TRD Research represented by a person in a white coat holding a clipboard and talking to a patient.
February 13, 2024in Depression 0 Comments 0 Likes

An Important Recent Study On Treatment-Resistant Depression: Population-Wide TRD Research

Treatment-Resistant Depression (TRD) remains a significant issue for many people and TRD research on a large population can help build scientific understanding that can lead to more effective treatment. A

by Dr. Bryan Bruno, Medical Director
Depression High-frequency rTMS represented by a conversation between a doctor and a patient
February 12, 2024in Depression 0 Comments 0 Likes

Does switching between high-frequency rTMS and theta burst TMS improve depression outcomes?

Neuromodulation techniques including transcranial magnetic stimulation (TMS) have emerged in recent decades as useful additional tools to improve the lives of people with treatment resistant Depression. In particular, two forms

by Dr. Bryan Bruno, Medical Director
Prev

Posts navigation

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Next

Recent Posts

  • Spravato NYC: A Breakthrough Nasal Spray for Treatment-Resistant Depression
  • Understanding the Paradoxical Effect of Antidepressants
  • Beyond Antidepressants: Why TMS May Be the Best Next Step in Battling Symptoms of Depression in Older Adults
  • Could Ozempic Be Used for Mental Health Treatment? Learn About GLP-1 Drugs
  • When Antidepressants Stop Working: An Update on “Poop Out”

Categories

  • anxiety
  • COVID-19
  • Depression
  • Depression Factors
  • Loneliness
  • Manhattan TMS
  • Resources
  • TMS
  • TMS Maintenance
  • Treatment
  • Types of Depression
  • Uncategorized
Site Map
  • Home
  • About
  • Services
  • Insurance Coverage
  • Frequently Asked Questions
  • Blog
Copyright © 2024 Mid City TMS. All rights reserved. Designed by Online Optimism.
280 Madison Ave, Suite 1102, New York, NY 10016
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 650px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}